Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation

The clinical implementation of magnetic hyperthermia has experienced little progress since the first clinical trial was completed in 2005. Some of the hurdles to overcome are the reliable production of magnetic nanoparticles with controlled properties and the control of the temperature at the target...

Descripción completa

Detalles Bibliográficos
Autores principales: Luengo, Yurena, Díaz-Riascos, Zamira V., García-Soriano, David, Teran, Francisco J., Artés-Ibáñez, Emilio J., Ibarrola, Oihane, Somoza, Álvaro, Miranda, Rodolfo, Schwartz, Simó, Abasolo, Ibane, Salas, Gorka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331462/
https://www.ncbi.nlm.nih.gov/pubmed/35893782
http://dx.doi.org/10.3390/pharmaceutics14081526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331462/
https://www.ncbi.nlm.nih.gov/pubmed/35893782
http://dx.doi.org/10.3390/pharmaceutics14081526

Ejemplares similares